Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 1/2023

24-11-2022 | Breast Cancer | Editorial

A message from the new editor-in-chief

Author: Takayuki Ueno

Published in: Breast Cancer | Issue 1/2023

Login to get access

Excerpt

I am honored to be named the editor-in-chief of the journal Breast Cancer in November 2022. Breast Cancer, launched in 1994, is the official journal of the Japanese Breast Cancer Society, which contributes to progress in the breast cancer research including basic, translational and clinical research, and develops a new focus and new perspectives for all who are concerned with breast cancer. …
Metadata
Title
A message from the new editor-in-chief
Author
Takayuki Ueno
Publication date
24-11-2022
Publisher
Springer Nature Singapore
Published in
Breast Cancer / Issue 1/2023
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-022-01417-2

Other articles of this Issue 1/2023

Breast Cancer 1/2023 Go to the issue

Original Article

The effects of home-based exercise therapy for breast cancer-related fatigue induced by radical radiotherapy

Original Article

Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy

Original Article

Sarcopenia detected with bioelectrical impedance versus CT scan and chemotherapy tolerance in patients with early breast cancer

Correction

Correction to: miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast

Original Article

Artificial intelligence computer-aided detection enhances synthesized mammograms: comparison with original digital mammograms alone and in combination with tomosynthesis images in an experimental setting

Original Article

Patient preferences for features of HER2-targeted treatment of advanced or metastatic breast cancer: a discrete-choice experiment study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits